Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Iranian Journal of Pharmaceutical Research is Scopus-indexed (Q2, CiteScore 2.9), WoS SCIE. Published by Brieflands.
Checked against the index lists dated .
ISSN 1726-6890Verify ISSN ↗1735-0328Verify ISSN ↗
Publisher: Brieflands
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 36 / 79 | 55th | Q2 |
| Pharmacology (medical) | 165 / 278 | 40th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q2, CiteScore 2.9.
Iranian Journal of Pharmaceutical Research is Q2 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 36 of 79) and Q3 in Pharmacology (medical) (rank 165 of 278), by CiteScore 2025.
Iranian Journal of Pharmaceutical Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.9, which places it in quartile Q2 at the 55th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.425, quartile Q2, with an H-index of 70.
Iranian Journal of Pharmaceutical Research is published by Brieflands. Its print ISSN is 1726-6890 and its online ISSN is 1735-0328.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Iranian Journal of Pharmaceutical Research has an h-index of 38 and a 2-year mean of 1.3 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q2. On 2-year citations it ranks #39 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Iranian Journal of Pharmaceutical Research published 110 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from Iran (53.5%), China (22.2%) and Indonesia (3.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.